<b>Subclinical stent edge effects</b>

Subclinical drug-eluting stent edge effect (sDES-EE) was more common (about 70.63%) after 1 year post PCI, only sDES-EE with stent-edge minimal luminal area reduction by &gt;25% predicting a significant increase in edge effect related target lesion failure (EE-TLF) at the 5-year follow-up.亚临床药物洗脱支架边缘效应（subclinical drug-eluting stent edge effect, sDES-EE）在经皮冠状动脉介入治疗（percutaneous coronary intervention, PCI）后1年的发生率约为70.63%，较为常见；仅伴支架边缘最小管腔面积减少＞25%的sDES-EE，可预测5年随访期间边缘效应相关靶病变失败（edge effect related target lesion failure, EE-TLF）的发生风险显著升高。